MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt flag Egypt · Delayed Price · Currency is EGP
794.00
+0.12 (0.02%)
At close: Aug 5, 2026

MINAPHARM Pharmaceuticals Cash Flow Statement

Millions EGP. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
40.22157.07-31.99612.66466.41
Depreciation & Amortization
380.18284.71192.23132.8685.99
Loss (Gain) From Sale of Assets
0.155.670.17--0.46
Provision & Write-off of Bad Debts
204012.64-2.67-8.91
Other Operating Activities
18.86158.86-88.9281.6490.93
Change in Accounts Receivable
279.66-271.35-147.28-168.51-22.41
Change in Inventory
-277.91-180.96-226.43-171.08-83.29
Change in Accounts Payable
-58.45265.839.82265.15-91.57
Change in Other Net Operating Assets
62.11-238.28352.1-188.28-229.4
Operating Cash Flow
464.81221.51102.34561.77207.28
Operating Cash Flow Growth
109.83%116.44%-81.78%171.03%-52.58%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-787.8-918.96-1,395-1,160-387.87
Sale of Property, Plant & Equipment
--0.17-0.76
Sale (Purchase) of Intangibles
-3.94-0.09-10.65-2.03-1.82
Other Investing Activities
63.8845.2600-0.01
Investing Cash Flow
-727.85-573.79-1,405-1,162-388.94

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
5,9622,4961,020494.8-
Long-Term Debt Issued
909.351,334459.34636.62425.73
Total Debt Issued
6,8713,8301,4791,131425.73
Short-Term Debt Repaid
-6,388-2,227---205.3
Long-Term Debt Repaid
-1,870-292.72-128.71-12.15-11.86
Total Debt Repaid
-8,258-2,520-128.71-12.15-217.16
Net Debt Issued (Repaid)
-1,3861,3101,3501,119208.57
Issuance of Common Stock
2,173----
Repurchase of Common Stock
----69.63-
Common Dividends Paid
-60.31-40.16-53.87-57.79-49.8
Other Financing Activities
-27.4746.35-0.082.31-3.2
Financing Cash Flow
699.341,3161,296994.16155.57

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
33.065.49230.86317.88-13.97
Miscellaneous Cash Flow Adjustments
-----1.5
Net Cash Flow
469.35969.43224.34711.56-41.56

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-322.99-697.45-1,292-598.45-180.6
Free Cash Flow Growth
-----
Free Cash Flow Margin
-5.02%-12.46%-33.21%-16.53%-6.01%
Free Cash Flow Per Share
-29.19-63.04-116.81-52.16-14.69
Levered Free Cash Flow
-183.62-362.97-1,317-622.61-139.42
Unlevered Free Cash Flow
284.288.07-1,158-583.75-108.9

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
748.64593.68254.4662.1748.84
Cash Income Tax Paid
76.8426.07132.95182.39154.77
Change in Working Capital
5.4-424.7918.21-262.72-426.67